Renal Insufficiency, Chronic

• 

  Subject Areas on Research

  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. 
  • A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda. 
  • A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. 
  • A massive pelvic mucocele presenting as a cystic sacral mass. 
  • A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 
  • A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. 
  • A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia. 
  • A rose by any other name: is stage 3a chronic kidney disease really a disease? 
  • A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry. 
  • A varying patient safety profile between black and nonblack adults with decreased estimated GFR. 
  • ACR Appropriateness Criteria(®) on renal failure. 
  • APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study. 
  • APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy. 
  • Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. 
  • Acid Load and Phosphorus Homeostasis in CKD. 
  • Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. 
  • Active vitamin D and survival. 
  • Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. 
  • Acute kidney injury and chronic kidney disease after cardiac surgery. 
  • Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response. 
  • Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry. 
  • Ambulatory blood pressure in chronic kidney disease: do ethnic disparities exist? 
  • An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States. 
  • Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease. 
  • Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome? 
  • Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease? 
  • Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients. 
  • Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. 
  • Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. 
  • Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults. 
  • Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. 
  • Association of Fitness With Racial Differences in Chronic Kidney Disease. 
  • Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission. 
  • Association of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease. 
  • Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults. 
  • Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. 
  • Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction. 
  • Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. 
  • Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease. 
  • Atrial Fibrillation and Risk of ESRD in Adults with CKD. 
  • Barriers to Achieving Economies of Scale in Analysis of EHR Data. A Cautionary Tale. 
  • Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function. 
  • Biomarkers of cardiovascular stress and incident chronic kidney disease. 
  • Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. 
  • Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease. 
  • Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly. 
  • Brain-kidney cross-talk: Definition and emerging evidence. 
  • Branch chain amino acids: biomarkers of health and disease. 
  • Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database. 
  • CKD as a Model for Improving Chronic Disease Care through Electronic Health Records. 
  • CKD of Uncertain Etiology: A Systematic Review. 
  • Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. 
  • Cardiorenal interactions: insights from the ESCAPE trial. 
  • Cardiovascular benefits of SGLT2 inhibition in diabetes and chronic kidney diseases. 
  • Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). 
  • Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. 
  • Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. 
  • Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care. 
  • Challenges perceived by primary care providers to educating patients about chronic kidney disease. 
  • Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial. 
  • Changes in Antihypertensive Therapy After Renal Transplantation. 
  • Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. 
  • Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments. 
  • Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. 
  • Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke. 
  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. 
  • Chronic kidney disease and recurrent falls in nursing home residents: a retrospective cohort study. 
  • Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial. 
  • Chronic kidney disease and stroke. 
  • Chronic kidney disease anemia management: what should be done? 
  • Chronic kidney disease in low- and middle-income countries. 
  • Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population. 
  • Chronic pain and analgesic use in CKD: implications for patient safety. 
  • Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. 
  • Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. 
  • Clinical imaging of vascular disease in chronic kidney disease. 
  • Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease. 
  • Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. 
  • Common variants in Mendelian kidney disease genes and their association with renal function. 
  • Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. 
  • Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. 
  • Comorbidities in Heart Failure: Are There Gender Differences? 
  • Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. 
  • Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. 
  • Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. 
  • Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. 
  • Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome. 
  • Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. 
  • Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure. 
  • Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease. 
  • Consideration of ICD-9 code-derived disease-specific safety indicators in CKD. 
  • Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. 
  • Contemporary mineral metabolism for clinicians and scientists: introduction. 
  • Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. 
  • Correction of anemia with epoetin alfa in chronic kidney disease. 
  • Correlates of left ventricular mass in chronic hemodialysis recipients. 
  • Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. 
  • Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study. 
  • Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. 
  • Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure. 
  • Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. 
  • Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. 
  • Depression in patients with chronic kidney disease on dialysis in Saudi Arabia. 
  • Development and validation of a cross-cultural knowledge, attitudes, and practices survey instrument for chronic kidney disease in a Swahili-speaking population. 
  • Device therapy in heart failure patients with chronic kidney disease. 
  • Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. 
  • Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions. 
  • Diabetic kidney disease: a report from an ADA Consensus Conference. 
  • Dietary acid load: a novel nutritional target in chronic kidney disease? 
  • Dietary and commercialized fructose: Sweet or sour? 
  • Disordered FGF23 and mineral metabolism in children with CKD. 
  • Disparities in the burden, outcomes, and care of chronic kidney disease. 
  • Distribution of survival times in a real-world cohort of older adults with chronic kidney disease: the median may not be the message. 
  • Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. 
  • Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? 
  • Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. 
  • Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials. 
  • Effect of Genetic African Ancestry on eGFR and Kidney Disease. 
  • Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS. 
  • Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. 
  • Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials. 
  • Effect of renal function on antihypertensive drug safety and efficacy in children. 
  • Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial. 
  • Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. 
  • Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. 
  • Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. 
  • Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial. 
  • Effects of phosphate binders in moderate CKD. 
  • Effects of serum creatinine calibration on estimated renal function in african americans: the Jackson heart study. 
  • Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. 
  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. 
  • Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. 
  • Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. 
  • Estimation of GFR in South Asians: a study from the general population in Pakistan. 
  • Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis. 
  • Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults. 
  • Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease. 
  • Evaluation of renal function before and after percutaneous mitral valve repair. 
  • Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. 
  • Exome-Based Rare-Variant Analyses in CKD. 
  • Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation. 
  • FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. 
  • FGF23 and Left Ventricular Hypertrophy in Children with CKD. 
  • FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. 
  • FGF23 modifies the relationship between vitamin D and cardiac remodeling. 
  • Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population. 
  • Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study. 
  • Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. 
  • Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study. 
  • Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. 
  • Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. 
  • Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function. 
  • Fibroblast growth factor 23 and Inflammation in CKD. 
  • Fibroblast growth factor 23 and incident CKD in type 2 diabetes. 
  • Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. 
  • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. 
  • Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. 
  • Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. 
  • Fibroblast growth factor-23 and cardiovascular events in CKD. 
  • Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes. 
  • Folic acid supplementation and chronic kidney disease progression. 
  • Food Access, Chronic Kidney Disease, and Hypertension in the U.S. 
  • Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study. 
  • Genetic Abrogation of Adenosine A3 Receptor Prevents Uninephrectomy and High Salt-Induced Hypertension. 
  • Genetic African Ancestry and Markers of Mineral Metabolism in CKD. 
  • Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 
  • Genetic background influences cardiac phenotype in murine chronic kidney disease. 
  • Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Getting the urine to the lab: time to think outside of the specimen cup. 
  • Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. 
  • HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. 
  • Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. 
  • Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection. 
  • Health information technology (IT) to improve the care of patients with chronic kidney disease (CKD). 
  • Heart failure with preserved ejection fraction: a nephrologist-directed primer. 
  • Heavy metal nephropathy: considerations for exposure analysis. 
  • Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. 
  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. 
  • Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective. 
  • Hepcidin and disordered mineral metabolism in chronic kidney disease. 
  • High-dose IV iron for anemia correction in chronic kidney disease. 
  • High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target? 
  • Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. 
  • Hospital discharge communications during care transitions for patients with acute kidney injury: a cross-sectional study. 
  • Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. 
  • Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. 
  • ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials. 
  • Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease. 
  • Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality. 
  • Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients. 
  • Impact of automated reporting of estimated glomerular filtration rate in the veterans health administration. 
  • Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial. 
  • Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR. 
  • Impact of renal dysfunction on acute coronary syndrome evaluation in observation unit patients. 
  • Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. 
  • Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. 
  • Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study. 
  • Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. 
  • Improving Primary Care for Patients With CKD in the Digital Era. 
  • Improving the prediction of hypertensive target organ damage using novel markers: lessons from retinal vascular imaging research. 
  • In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia. 
  • In reply to 'validating GFR estimating samples with clinical outcomes'. 
  • In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease? 
  • Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. 
  • Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients). 
  • Incorporating Geriatric Assessment into a Nephrology Clinic: Preliminary Data from Two Models of Care. 
  • Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study. 
  • Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. 
  • Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients. 
  • Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. 
  • Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. 
  • Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease. 
  • Influence of chronic kidney disease on warfarin therapy for atrial fibrillation. 
  • Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease. 
  • Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes? 
  • Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells. 
  • International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. 
  • Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. 
  • Is chronic kidney disease associated with diabetic retinopathy in Asian adults? 
  • Is renal function associated with early age-related macular degeneration? 
  • Is there something better than the best marker of kidney function? 
  • Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. 
  • Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 
  • Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. 
  • Knowledge, Attitudes, and Practices Associated with Chronic Kidney Disease in Northern Tanzania: A Community-Based Study. 
  • Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. 
  • Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population. 
  • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. 
  • Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. 
  • Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Longitudinal FGF23 Trajectories and Mortality in Patients with CKD. 
  • Low use of routine medical care among African Americans with high CKD risk: the Jackson Heart Study. 
  • Low-Dose Allopurinol Promotes Greater Serum Urate Lowering in Gout Patients with Chronic Kidney Disease Compared with Normal Kidney Function. 
  • MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. 
  • Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry. 
  • Management of Coronary Disease in Patients with Advanced Kidney Disease. 
  • Management of acute coronary syndromes in patients with renal dysfunction. 
  • Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
  • Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. 
  • Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD. 
  • Markers of Renal Function in Older Adults Completing a Higher Protein Obesity Intervention and One Year Later: Findings from the MEASUR-UP Trial. 
  • Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. 
  • Metabolic Changes with Base-Loading in CKD. 
  • Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. 
  • Mineral metabolites and CKD progression in African Americans. 
  • Minithoracotomy versus sternotomy for mitral surgery in patients with chronic renal impairment: a propensity-matched study. 
  • Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study. 
  • Mortality after myocardial infarction: the role of renal function and systolic and diastolic functions of the left ventricle. 
  • Nationwide Trends and Variations in Urological Surgical Interventions and Renal Outcome in Patients with Spina Bifida. 
  • Neighborhood clustering of non-communicable diseases: results from a community-based study in Northern Tanzania. 
  • Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study. 
  • Nephrotoxic contaminants in drinking water and urine, and chronic kidney disease in rural Sri Lanka. 
  • New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. 
  • New-onset hypertension and risk for chronic kidney disease in the Japanese general population. 
  • Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans. 
  • Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. 
  • Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. 
  • Novel Models for Health Care Delivery for CKD for Disadvantaged Populations. 
  • Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. 
  • Older Patients' Perspectives on Managing Complexity in CKD Self-Management. 
  • Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease. 
  • Optimizing SGLT inhibitor treatment for diabetes with chronic kidney diseases. 
  • Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review. 
  • Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction. 
  • Outcomes of Ureteroscopic Stone Treatment in Patients With Spinal Cord Injury. 
  • Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. 
  • Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. 
  • Patient Education and Support During CKD Transitions: When the Possible Becomes Probable. 
  • Patient discourse on chronic kidney disease monitoring: a qualitative study at a Veterans Affairs Renal Clinic. 
  • Patient-Reported Safety Events in Chronic Kidney Disease Recorded With an Interactive Voice-Inquiry Dial-Response System: Monthly Report Analysis. 
  • Patient-reported and actionable safety events in CKD. 
  • Patients' and Nephrologists' Evaluation of Patient-Facing Smartphone Apps for CKD. 
  • Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. 
  • Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. 
  • Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. 
  • Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease. 
  • Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study. 
  • Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation. 
  • Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. 
  • Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study. 
  • Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF. 
  • Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. 
  • Phosphate REINs in the renoprotective benefit of ACE inhibition. 
  • Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. 
  • Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. 
  • Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). 
  • Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure. 
  • Plasticity of renal erythropoietin-producing cells governs fibrosis. 
  • Postoperative Impact of Diabetes, Chronic Kidney Disease, Hemodialysis, and Renal Transplant After Total Hip Arthroplasty. 
  • Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease. 
  • Prediction, progression, and outcomes of chronic kidney disease in older adults. 
  • Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). 
  • Predictors of length of hospital stay in elderly hip fracture patients. 
  • Premature T Cell Senescence in Pediatric CKD. 
  • Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease. 
  • Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry. 
  • Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. 
  • Prevalence of apparent treatment-resistant hypertension among individuals with CKD. 
  • Prevalence of chronic kidney disease in China. 
  • Prevalence of contraindications and prescription of pharmacologic therapies for gout. 
  • Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010. 
  • Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from Tanzania. 
  • Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study. 
  • Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. 
  • Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study. 
  • Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study. 
  • Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study. 
  • Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing? 
  • Proportion of US adults potentially affected by the 2014 hypertension guideline. 
  • Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm? 
  • Pruning the ricket thicket. 
  • Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study. 
  • Pulmonary Hypertension Subtypes and Mortality in CKD. 
  • Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial. 
  • Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program. 
  • Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. 
  • Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease. 
  • Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort. 
  • Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial. 
  • Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Recent advances in renal hypoxia: insights from bench experiments and computer simulations. 
  • Recognition of CKD after the introduction of automated reporting of estimated GFR in the Veterans Health Administration. 
  • Recycling to discover something new: the role of autophagy in kidney disease. 
  • Reducing CKD risks among vulnerable populations in primary care. 
  • Regional variation in chronic kidney disease and associated factors in hypertensive individuals in rural South Asia: findings from control of blood pressure and risk attenuation-Bangladesh, Pakistan and Sri Lanka. 
  • Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions. 
  • Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. 
  • Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. 
  • Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD. 
  • Renal function outcomes after laparoscopic renal cryoablation. 
  • Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery. 
  • Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function. 
  • Response to letter regarding article "Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease". 
  • Retinal Vascular Imaging Markers and Incident Chronic Kidney Disease: A Prospective Cohort Study. 
  • Retinal arteriolar narrowing and subsequent development of CKD Stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Retinal microvascular signs are associated with chronic kidney disease in persons with and without diabetes. 
  • Revamping the 'renal' diet: using foods to control phosphorus physiology. 
  • Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. 
  • Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease. 
  • Role of Acid-Base Homeostasis in Diabetic Kidney Disease. 
  • SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism. 
  • SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. 
  • Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. 
  • Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. 
  • Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. 
  • Screening for chronic kidney disease. 
  • Self-reported Medication Adherence and Adverse Patient Safety Events in CKD. 
  • Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes. 
  • Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. 
  • Setting an agenda for comparative effectiveness systematic reviews in CKD care. 
  • Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. 
  • Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. 
  • Socioeconomic status and microalbuminuria in an Asian population. 
  • Specialist and primary care physicians' views on barriers to adequate preparation of patients for renal replacement therapy: a qualitative study. 
  • Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. 
  • Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. 
  • Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. 
  • Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. 
  • Targeting Fall Risk in CKD. 
  • Telehealth Applications to Enhance CKD Knowledge and Awareness Among Patients and Providers. 
  • Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry. 
  • The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study. 
  • The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction. 
  • The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. 
  • The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. 
  • The Impact of Chronic Kidney Disease on Postoperative Outcomes in Patients Undergoing Lumbar Decompression and Fusion. 
  • The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. 
  • The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. 
  • The association between smoking and long-term outcomes after non-ST-segment elevation myocardial infarction in older patients. 
  • The association between urbanization and reduced renal function: findings from the China Health and Nutrition Survey. 
  • The balance of the evidence on acid-base homeostasis and progression of chronic kidney disease. 
  • The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. 
  • The chronic kidney disease model: a general purpose model of disease progression and treatment. 
  • The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. 
  • The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. 
  • The growing burden of chronic kidney disease in Pakistan. 
  • The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. 
  • The last mile: translational research to improve CKD outcomes. 
  • The management of acute coronary syndromes in patients with chronic kidney disease. 
  • The need for collaboration to improve cardiovascular outcomes in patients with CKD. 
  • The pursuit of truth and beauty. 
  • Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing. 
  • Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. 
  • Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. 
  • Traditional Medicines and Kidney Disease in Low- and Middle-Income Countries: Opportunities and Challenges. 
  • Traditional medicine practices among community members with chronic kidney disease in northern Tanzania: an ethnomedical survey. 
  • Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. 
  • Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). 
  • Trends in anemia management in US hemodialysis patients 2004-2010. 
  • Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. 
  • Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension. 
  • Update on fibroblast growth factor 23 in chronic kidney disease. 
  • Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. 
  • Urological complications and vesicoureteral reflux following pediatric kidney transplantation. 
  • Usability Testing of a Sick-Day Protocol in CKD. 
  • Usability of a CKD educational website targeted to patients and their family members. 
  • Usability testing and acceptance of an electronic medication inquiry system for CKD patients. 
  • Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. 
  • Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease. 
  • Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. 
  • Using Zero Balance Ultrafiltration with Dialysate as a Replacement Fluid for Hyperkalemia during Cardiopulmonary Bypass. 
  • Using social media to create a professional network between physician-trainees and the American Society of Nephrology. 
  • Utility of implantable cardioverter defibrillators in chronic kidney disease. 
  • Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. 
  • Vascular calcification in chronic kidney disease: here to stay? 
  • Venous thromboembolism: yet another cardiovascular complication of chronic kidney disease? 
  • Vision Impairment in CKD Patients: Epidemiology, Mechanisms, Differential Diagnoses, and Prevention. 
  • Vitamin D deficiency and anemia in early chronic kidney disease. 
  • We still go for the jugular: implications of the 3SITES central venous catheter study for nephrology. 
  • Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4. 
• 

  Keywords of People

  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics